AAV-mediated delivery of leptin but not adiponectin improves metabolic health in a mouse model of congenital generalised lipodystrophy
This study demonstrates that AAV-mediated leptin gene therapy significantly improves metabolic health in a mouse model of congenital generalised lipodystrophy, whereas adiponectin delivery yields no beneficial effects, highlighting leptin's potential as a long-term therapeutic alternative to daily injections.